Jul 21, 2026 08:55AM
Jul 21, 2026 08:55AM
Jun 29, 2026 04:15PM
Jun 29, 2026 04:15PM
Jun 23, 2026 08:19AM
Jun 23, 2026 08:17AM
May 7, 2026 08:06AM Silo Pharma files patent for ibogaine treatment targeting brain injury
May 7, 2026 08:05AM
May 7, 2026 08:05AM
Apr 29, 2026 09:08AM
Apr 29, 2026 09:08AM
Apr 22, 2026 04:15PM
Apr 22, 2026 04:15PM
Dec 30, 2025 08:05AM Silo Pharma signs letter of intent with Allucent for phase 1 studies
Dec 30, 2025 08:05AM
Nov 17, 2025 08:05AM
Nov 17, 2025 08:05AM
Oct 23, 2025 08:45AM
Oct 23, 2025 08:45AM
Sep 9, 2025 09:10AM
Sep 9, 2025 09:10AM Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
Sep 3, 2025 08:25AM
Sep 3, 2025 08:25AM
Aug 19, 2025 08:05AM
Aug 19, 2025 08:05AM
Aug 5, 2025 08:32AM
Aug 5, 2025 08:32AM
Jul 16, 2025 08:45AM Silo Pharma completes dosing in PTSD drug safety study
Jul 16, 2025 08:45AM
Jul 7, 2025 08:16AM
Jul 7, 2025 08:15AM
Jun 11, 2025 09:03AM
Jun 11, 2025 09:00AM
May 21, 2025 08:56AM
May 21, 2025 08:55AM Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
May 14, 2025 04:08PM
May 14, 2025 04:07PM
May 14, 2025 08:40AM
May 14, 2025 08:40AM
Apr 30, 2025 08:11AM
Apr 30, 2025 08:11AM
Apr 30, 2025 08:11AM Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
Mar 26, 2025 08:43AM
Mar 26, 2025 08:40AM
Feb 26, 2025 01:30PM
Feb 26, 2025 01:30PM
Feb 18, 2025 08:51AM
Feb 18, 2025 08:50AM
Feb 11, 2025 07:45AM Silo Pharma (SILO) Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26
Feb 11, 2025 07:45AM

326,426 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All